Tesaro is re­port­ed­ly on the auc­tion block, but who can af­ford it?

Tesaro is up on the auc­tion block, The Wall Street Jour­nal is re­port­ing. But don’t be sur­prised if no one comes up and gob­bles this one up fast. An­a­lysts be­lieve Tesaro has a block­buster on its hands with its new­ly ap­proved PARP in­hibitor Ze­ju­la and it won’t go cheap.

The Jour­nal says that Waltham, MA-based Tesaro has sent out a re­quest for bids over the last few weeks, but in­ter­est seems tepid.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.